Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.04 USD | +1.65% | +10.28% | -16.75% |
Financials (USD)
Sales 2024 * | 632M | Sales 2025 * | 708M | Capitalization | 2.82B |
---|---|---|---|---|---|
Net income 2024 * | 109M | Net income 2025 * | 148M | EV / Sales 2024 * | 3.41 x |
Net cash position 2024 * | 659M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
28.1
x | P/E ratio 2025 * |
21
x | Employees | 352 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.18% |
Latest transcript on Corcept Therapeutics Incorporated
1 day | +1.65% | ||
1 week | +10.28% | ||
Current month | +15.95% | ||
1 month | +13.52% | ||
3 months | +17.51% | ||
6 months | +8.03% | ||
Current year | -16.75% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 21-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-03-11 |
George Baker
BRD | Director/Board Member | 81 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.71% | 0 M€ | -1.57% | ||
0.30% | 0 M€ | +3.60% | ||
0.27% | 0 M€ | -2.98% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 27.04 | +1.65% | 1,547,905 |
24-05-09 | 26.6 | +4.72% | 1,265,816 |
24-05-08 | 25.4 | +3.76% | 932,703 |
24-05-07 | 24.48 | +2.13% | 876,430 |
24-05-06 | 23.97 | -2.24% | 1,230,562 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.75% | 2.82B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- CORT Stock